Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dose Response Relationship, Drug”

99 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 99 results

Early research (Phase 1)Study completedNCT00029900
What this trial is testing

ADI-PEG in Patients With Metastatic Melanoma

Who this might be right for
MelanomaNeoplasm Metastasis
FDA Office of Orphan Products Development 15
Early research (Phase 1)Study completedNCT00000899
What this trial is testing

A Study on the Effect of Chemotherapy Combined With Anti-HIV Drugs in HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 10
Early research (Phase 1)Study completedNCT00000710
What this trial is testing

A Phase I Safety, Efficacy, and Pharmacokinetic Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Patients With AIDS or AIDS Related Complex

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 42
Large-scale testing (Phase 3)Study completedNCT00002124
What this trial is testing

A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3

Who this might be right for
HIV Infections
Pharmacia and Upjohn 1,250
Not applicableLooking for participantsNCT07183579
What this trial is testing

Effective Dosing of Burosumab in XLH

Who this might be right for
X-linked Hypophosphatemia (XLH)
University of Nottingham 120
Testing effectiveness (Phase 2)Ended earlyNCT00090194
What this trial is testing

Improving Transplant Options of Highly Sensitized Recipients Using IGIV-C, 10%

Who this might be right for
Kidney Failure, Chronic
National Institute of Allergy and Infectious Diseases (NIAID) 56
Not applicableEnded earlyNCT03320564
What this trial is testing

Infiltration Effect on SUV

Who this might be right for
Dose Response Relationship, Drug
Wake Forest University Health Sciences 2
Testing effectiveness (Phase 2)Study completedNCT00029874
What this trial is testing

Minocycline in Patients With Huntington's Disease

Who this might be right for
Huntington's Disease
FDA Office of Orphan Products Development 63
Early research (Phase 1)Study completedNCT00006279
What this trial is testing

The Safety of Nevirapine When Given to Breast-Feeding Babies From Birth to Age 6 Months

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 75
Not applicableStudy completedNCT00000718
What this trial is testing

A Clinical Trial of Alternating and Intermittent Regimens of 2',3'-Dideoxycytidine and 3'-Azido-3'-Deoxythymidine in the Treatment of Patients With AIDS and Advanced ARC

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 112
Testing effectiveness (Phase 2)Study completedNCT00002239
What this trial is testing

Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults

Who this might be right for
HIV Infections
Hoffmann-La Roche 68
Early research (Phase 1)Study completedNCT00006325
What this trial is testing

Safety, Tolerability, and Anti-HIV Activity of PEG-Intron in HIV-Positive Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 54
Testing effectiveness (Phase 2)Study completedNCT00000825
What this trial is testing

The Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 72
Large-scale testing (Phase 3)Study completedNCT00197353
What this trial is testing

Study of Different Concentrations of Epidural Bupivacaine for the Effects on Vasodilatation and Sensory Block

Who this might be right for
Intraoperative Complications
Hadassah Medical Organization 60
Testing effectiveness (Phase 2)Study completedNCT00012467
What this trial is testing

Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis

Who this might be right for
Meningitis, CryptococcalHIV Infections
InterMune 60
Testing effectiveness (Phase 2)Study completedNCT00000909
What this trial is testing

Evaluate the Effects of Giving IL-2 Alone to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3 Who Do Not Wish to Receive Anti-HIV Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Post-approval studies (Phase 4)Study completedNCT02253199
What this trial is testing

The Effect of Age on the Median Effective Dose (ED50) of Intranasal Dexmedetomidine for Rescue Sedation Following Failed Sedation With Oral Chloral Hydrate During Magnetic Resonance Imaging

Who this might be right for
AgedDrugDose-Response Relationship
Guangzhou Women and Children's Medical Center 120
Post-approval studies (Phase 4)Study completedNCT02568345
What this trial is testing

Sugammadex ED90 Dose in the Obese Patients

Who this might be right for
Incomplete Reversal of Neuromuscular Block
Faculdade de Ciências Médicas da Santa Casa de São Paulo 31
Testing effectiveness (Phase 2)Study completedNCT03959566
What this trial is testing

PanACEA Sutezolid Dose-finding and Combination Evaluation

Who this might be right for
Pulmonary TuberculosisOther Specified Pulmonary Tuberculosis
Michael Hoelscher 75
Early research (Phase 1)Study completedNCT00001009
What this trial is testing

Dextran Sulfate in HIV-Infected Patients and in Patients With AIDS or AIDS Related Complex (ARC)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 60
Load More Results